TerrAscend (TER) Q4 2024 earnings summary

Executive summary

• Achieved $306.7M net revenue for FY 2024 and $74.4M in Q4, with gross margins of 48.9% and 50.2% respectively; 10th consecutive quarter of positive operating cash flow and 6th of positive free cash flow.

• Maintained #1 market share in New Jersey throughout 2024 and expanded Maryland market share from #13 to #6, with Maryland reaching a $70M run rate and gross margin doubling to over 50%.

• Entered Ohio as the sixth state via acquisition, targeting leading retail footprint as adult-use market opens.

• Strengthened balance sheet with $140M non-dilutive debt financing, extending maturities to 2028, and launched a $10M share repurchase program.

• Implemented company-wide ERP system, enhancing efficiency and enabling further expense reductions.

Financial highlights

• FY 2024 net revenue: $306.7M, down from $317.3M in 2023; Q4 2024 net revenue: $74.4M, up slightly from Q3.

• FY 2024 gross profit margin: 48.9%; Q4 2024: 50.2%, up from 48.8% in Q3.

• FY 2024 adjusted EBITDA: $60.7M (19.8% margin); Q4 2024: $15.1M (20.3% margin).

• FY 2024 net loss: $72.7M, including $47.8M non-cash impairment charges, mainly related to Michigan.

• Q4 2024 net cash from operations: $9.7M; free cash flow: $5.0M; full-year free cash flow: $28.6M.

Outlook and guidance

• Q1 2025 revenue expected to decline low- to mid-single digits due to seasonality; gross margin to remain around 50%.

• Further G&A reductions expected, targeting $10M in annual savings for 2025.

• 2025 capex projected at ~$10M, focused on Northeast growth, margin expansion, and facility upgrades.

• Ongoing facility expansions in New Jersey and Maryland to support innovation and product growth.

• Preparing for potential adult-use legalization in Pennsylvania.